Please login to the form below

Not currently logged in
Email:
Password:

DS Biopharma promotes Dr Markus Weissbach

He moves to chief operating officer at the Irish drug discovery firm

Dr Markus Weissbach has been appointed chief operating officer at Irish drug discovery and development company DS Biopharma.

He previously served as the Dublin-based firm's medical director, which he joined after a spell running his own consultancy.

Prior to that his 25years in the pharma, biotech and CRO industries saw him hold senior roles that included chief medical officer (Europe) at Novartis Vaccines and Diagnostics, president of Icon Clinical Research (Europe) and director of clinical research and development at Takeda R&D (Europe).

Commenting on his new appointed, DS Biopharma's executive chairman Dr John Climax said: “I am delighted to welcome Dr Markus Weissbach into his new role within the DS team and I look forward to working with him in advancing the DS portfolio.”

14th September 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics